Quantcast

Latest Cardiac surgery Stories

2014-04-02 00:23:28

These and Other Studies Reinforce Global Commitment to the Development of Innovative Therapies to Improve Care for Patients with Cardiovascular Disease NATICK, Mass., April 1, 2014 /PRNewswire/ -- Reinforcing its position as a global leader in bringing new therapies to patients with heart and cardiovascular disease, Boston Scientific Corporation (NYSE: BSX) reported favorable results in studies related to cardiac resynchronization therapy (CRT), platinum chromium stent platforms and...

2014-03-31 13:26:39

Among patients undergoing aortic valve replacement using a catheter tube, a comparison of two types of heart valve technologies, balloon-expandable or self-expandable valve systems, found a greater rate of device success with the balloon-expandable valve, according to a JAMA study released online to coincide with presentation at the 2014 American College of Cardiology Scientific Sessions. Transcatheter aortic valve replacement (TAVR) has emerged as a new option for patients with severe...

2014-03-31 13:22:25

The most frequently used mechanical circulatory assist device in the world may have untapped potential, physicians say. One of many uses for the intra-aortic balloon pump is helping ensure adequate oxygen and blood delivery to a heart struggling to resume beating in the aftermath of coronary bypass surgery, said Dr. Mary Arthur, cardiovascular anesthesiologist at the Medical College of Georgia and Georgia Regents Health System. However physicians have been advised not to use the balloon...

2014-03-31 12:28:59

U-M's Dr. Aimee Armstrong reports valve had low rates of narrowing, leakage, and other adverse events, during American College of Cardiology meeting ANN ARBOR, Mich., March 31, 2014 /PRNewswire-USNewswire/ -- The first post-FDA approval study of a non-surgically implanted replacement pulmonary valve showed strong short- and mid-term results for the device in patients with certain congenital heart defects, according to research presented by a U-M pediatric interventional cardiologist...

2014-03-26 12:29:52

Transcatheter Aortic Valve Replacement Devices Will See Rapid Adoption, But Are Unlikely to Match Success Seen in US and Europe, According to Findings from Decision Resources Group BURLINGTON, Mass., March 26, 2014 /PRNewswire/ -- Decision Resources Group finds that the Latin American market for heart valve devices will approach $200 million by 2022, with rapid growth driven largely by favorable demographics and the rising adoption of transcatheter heart valve (THV) products, including...

2014-03-25 16:26:29

Thought Leaders Present Cases with Etiologies That Lead to End-Stage Biventricular Heart Failure, Including Cardiac Tumor, Transplant Rejection, Ventricular Septal Defect and Chagas Disease TUCSON, Ariz., March 25, 2014 /PRNewswire/ -- Thought leaders in the U.S. heart transplant and mechanical device field recently detailed the best practices for a growing list of uses for the SynCardia temporary Total Artificial Heart, demonstrating how the world's first and only FDA, Health Canada and CE...

2014-03-24 23:24:56

NewYork-Presbyterian/Columbia University Medical Center marked a milestone in cardiac care after completing its 1,000th transcatheter aortic valve replacement (TAVR), a procedure for patients who need a new heart valve but are too sick to undergo open-heart surgery. New York, NY (PRWEB) March 24, 2014 Pioneered by Newyork-presbyterian/columbia Experts, Minimally Invasive Procedure Offers New Hope for Patients Unable to Undergo Open-heart Surgery NewYork-Presbyterian/Columbia University...

2014-03-21 08:24:33

CHICAGO, March 21, 2014 /PRNewswire/ - Allegations continue surrounding the testing of two annuloplasty rings, invented by the chief of cardiac surgery, Dr. Patrick McCarthy at Northwestern University, the Myxo Ring, and the IMR Ring (invented by McCarthy, and colleagues). Both rings were implanted in patients, allegedly, without their consent. These rings considered to be similar to the pre-existing devices, which never underwent FDA approval or FDA registration for legal sales on...

2014-03-10 12:26:31

Launch of Transcatheter Technologies In Australia and China In 2014 Will Be Major Growth Driver, According to Findings from Decision Resources Group BURLINGTON, Mass., March 10, 2014 /PRNewswire/ -- Decision Resources Group finds that the Asia Pacific heart valve device market will more than double through 2022 with the introduction of transcatheter heart valves. Already available in South Korea, these devices are expected to be launched in China and Australia this year and in India in 2016....

2014-03-07 08:25:44

DUBLIN, Mar. 07, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/hsgjjr/european_patient ) has announced the addition of the "Concise Analysis of European Patient Flow & Epidemiology : Aortic Valve Disease Care Track" report to their offering. (Logo:http://photos.prnewswire.com/prnh/20130307/600769) This report provides insights into Aortic Valve Disease epidemiology with key indicators such as prevalence and incidence before analyzing...


Latest Cardiac surgery Reference Libraries

0_886104d1c1c698f3a531e056704457d5
2010-10-14 16:46:25

The artificial heart, a mechanical heart replacement, is typically used in order to bridge the time to heart transplant or to replace the heart in case a transplant is impossible. Often ventricular assist devices are confused with mechanical hearts because the assist the heart through pumps. They are also different from a cardiopulmonary bypass machine which is an external device used to provide the function of the heart and lungs. CPBs are usually only used for a few hours at a time,...

More Articles (1 articles) »
Word of the Day
out-herod
  • In the phrase to out-herod Herod, to be more violent than Herod (as represented in the old mystery plays); hence, to exceed in any excess of evil.
Herod refers to 'Herod the Great,' a Roman client king and 'a madman who murdered his own family and a great many rabbis.' According to the OED, the term is 'chiefly with allusion to Shakespeare's use' in Hamlet.
Related